METTL1 was negatively correlated with MSI and TMB in COAD but positively correlated with markers of HNSC, KICH, PRAD, and STAD, suggesting that METTL1 may have an impact on ICB therapeutic response in cancers such as HNSC. This evidence concerns the gene METTL1 and cancer.